Hoff, Gretchen2012-09-152012-09-152012-04-18https://hdl.handle.net/11299/133451Faculty mentor: Erica Warlick, MDThe prognostic outcome of acute myelogenous leukemia (AML) patients with a history of myelodysplastic syndrome is significantly worse than those without prior MDS. It is thought that approximately 40% of AML multilineage dysplasia (MLD) patients have a history of MDS. In this study a pool of AML-MLD patients were retrospectively investigated for primary MDS.en-USDepartment of MedicineHematology, Oncology, and TransplantPresentation